Quick Ratio
Higher than 53% of Healthcare sector peers
Updated 22h ago
Sector Performance
53th percentileVEEV
1.45x
Sector Median
1.31x
Sector Avg
2.65x
Deep Analysis
The quick ratio measures a company's ability to pay short-term obligations using its most liquid assets, with a value above 1.0x generally considered healthy.
Veeva's current quick ratio of 1.45x is above the sector median of 1.31x, placing it in the 53rd percentile among Healthcare peers. However, the metric is decreasing, with a quarter-over-quarter decline of -69.0% from the prior quarter's 4.67x, and a year-over-year change is not available. The combination of a still-adequate level but a sharp downward trend raises caution about near-term liquidity, though the ratio remains above the 1.0x threshold. This mixed signal does not directly contradict the overall BULLISH verdict, as the company’s liquidity is still above peer median, but investors should monitor whether the decline stabilizes.
Frequently Asked Questions
What does the Quick Ratio tell investors about VEEV?
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
How is the Quick Ratio calculated?
Quick Ratio is calculated as: (Cash + Receivables) / Current Liabilities.
How does VEEV's Quick Ratio compare to its sector?
VEEV's Quick Ratio of 1.45x compares to a Healthcare sector median of 1.31x, placing it in the 53th percentile.
Who are VEEV's closest peers by Quick Ratio?
The closest Healthcare peers by Quick Ratio include: BIO (1.02x), BAX (1.01x), BSX (1.00x), BMY (0.91x), DGX (0.91x).
The Formula
(Cash + Receivables) / Current Liabilities
Why It Matters
A strict liquidity test. Values below 1.0 suggest a company may struggle to cover short-term obligations without selling inventory.
Master VEEV's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full VEEV research report →VEEV
1.45x
Sector Median
1.31x
Sector Avg
2.65x
How VEEV's Quick Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.